跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,195 条关于
“Abelson Tyrosine Kinase”
全部
4,195
临床试验
1,924
药物
539
机构
25
资讯
1,707
去年
Nilotinib Shows Promise in Dementia with Lewy Bodies
10个月前
Inhibikase Therapeutics Advances IKT-001 to Global Phase 3 Study for Pulmonary Arterial Hypertension
4个月前
ABLi Therapeutics Strengthens Board with Neurodegeneration Expert Dr. Rachelle Doody Ahead of Phase 3 Trials
去年
FDA Supports Novel Endpoints for ABLi Therapeutics' Risvodetinib Phase 3 Trial in Parkinson's Disease
去年
Olverembatinib Shows Promise in TKI-Resistant CML and Ph+ ALL
7个月前
ABLi Therapeutics Partners with Michael J. Fox Foundation to Test Risvodetinib in Parkinson's Prevention Trial
9个月前
Tyrosine Kinase Inhibitors and Gene Therapies Show Promise for Wet AMD Treatment
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
去年
Ruxolitinib Plus TKI Therapy Shows Promise in Chronic Myeloid Leukemia
去年
ESK981 Plus Nivolumab Fails to Show Antitumor Activity in Metastatic Castration-Resistant Prostate Cancer
第 1 页,共 171 页
上一页
下一页